Sinopharm Group Co Financial Overview
Sinopharm Group Co's market cap is currently $7.96B. The company's EPS TTM is $0.08351509; its P/E ratio is 8.16; and it has a dividend yield of 3.82%. Sinopharm Group Co is scheduled to report earnings on October 26, 2025, and the estimated EPS forecast is $0.16. See an overview of income statement, balance sheet, and cash flow financials.
